1. Home
  2. NCV vs HRTX Comparison

NCV vs HRTX Comparison

Compare NCV & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NCV
  • HRTX
  • Stock Information
  • Founded
  • NCV 2003
  • HRTX 1983
  • Country
  • NCV United States
  • HRTX United States
  • Employees
  • NCV N/A
  • HRTX N/A
  • Industry
  • NCV Finance Companies
  • HRTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • NCV Finance
  • HRTX Health Care
  • Exchange
  • NCV Nasdaq
  • HRTX Nasdaq
  • Market Cap
  • NCV 326.0M
  • HRTX 276.1M
  • IPO Year
  • NCV N/A
  • HRTX 1987
  • Fundamental
  • Price
  • NCV $14.75
  • HRTX $1.35
  • Analyst Decision
  • NCV
  • HRTX Strong Buy
  • Analyst Count
  • NCV 0
  • HRTX 2
  • Target Price
  • NCV N/A
  • HRTX $4.50
  • AVG Volume (30 Days)
  • NCV 405.1K
  • HRTX 2.6M
  • Earning Date
  • NCV 01-01-0001
  • HRTX 08-08-2025
  • Dividend Yield
  • NCV 12.48%
  • HRTX N/A
  • EPS Growth
  • NCV N/A
  • HRTX N/A
  • EPS
  • NCV N/A
  • HRTX N/A
  • Revenue
  • NCV N/A
  • HRTX $149,694,000.00
  • Revenue This Year
  • NCV N/A
  • HRTX $10.62
  • Revenue Next Year
  • NCV N/A
  • HRTX $12.99
  • P/E Ratio
  • NCV N/A
  • HRTX N/A
  • Revenue Growth
  • NCV N/A
  • HRTX 9.78
  • 52 Week Low
  • NCV $2.84
  • HRTX $1.04
  • 52 Week High
  • NCV $3.59
  • HRTX $2.68
  • Technical
  • Relative Strength Index (RSI)
  • NCV 66.05
  • HRTX 36.48
  • Support Level
  • NCV $14.27
  • HRTX $1.33
  • Resistance Level
  • NCV $14.78
  • HRTX $1.43
  • Average True Range (ATR)
  • NCV 0.14
  • HRTX 0.07
  • MACD
  • NCV 0.01
  • HRTX 0.02
  • Stochastic Oscillator
  • NCV 90.57
  • HRTX 45.45

About NCV Virtus Convertible & Income Fund of Beneficial Interest

Virtus Convertible & Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide total return through a combination of capital appreciation and high current income. It intends to achieve the objective by investing in a portfolio of domestic convertible securities and non-convertible income-producing securities. Its portfolio of investments includes Software, the Internet, the Commercial Services sector in the form of Convertible Bonds and Notes, and Media, Oil, Gas & Consumable Fuels, and Entertainment sector in the form of Corporate Bonds and Notes.

About HRTX Heron Therapeutics Inc.

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Share on Social Networks: